The Ontario Brain Institute (OBI) in collaboration with the Institute for Clinical and Evaluative Sciences (ICES) released a report this July that provides new Ontario-specific findings for thirteen brain disorders, including epilepsy.
Epilepsy Ontario is currently looking for new board members
with a high degree of personal commitment to our cause who have the energy to
devote up to 12 hours per month.
Welcome Debra Swan!
Sadly, we are saying good-bye to Elizabeth Moss our Client Services Coordinator. We are now accepting applications for this position.
Wednesday, July 29th marks the first session of our monthly epilepsy support group meetings.
Fire Truck Pull Volunteers. Thank you!
World Brain Day 2015 focuses on Epilepsy
Epilepsy Ontario has learned that two clobazam drugs are in shortage:
APO-clobazam (DIN 02244638) is on back-order. The company's estimated resupply date is July 5, 2015.
PMS-clobazam (DIN 02244474) is not available. Resupply date is unknown.
World Health Assembly approved the WHO Resolution on the Global Burden of Epilepsy.
Interested in epilepsy support groups? Take a minute to complete our survey.
Epilepsy Ontario has learned there is a serious shortage of acetazolamide tablets.
- Acetazolamide (AA Pharma) is on back-order. The manufacturer estimates that additional supply will be available on June 30.
Drug Identification Number or DIN is 00545015
- Acetazolam (Valeant Canada LP) has been discontinued.
Drug Identification Number or DIN is 00295019
No upcoming events, check back later